CurrentPartnering

Established in 2007, CurrentPartnering is a company, publishing deal terms and business development best practice reports, which offer access to business intelligence data and description of the recent and emerging trends in the partnering activity across a broad range of the life sciences industries. CurrentPartnering helps their clients to get ready for negotiations and gain better understanding of the potential deal structures available to them.

The list of CurrentPartnering’s customers is represented by numerous bigpharma, diagnostics, pharmaceutical and biotech companies. The reports published by CurrentPrartnering deliver to their clients assessment of potential partnerships terms, in-depth insights into the major financial terms and other key issues essential for successful partnering. CurrentPartnering supplies its customers with cutting-edge information required to optimize their partnering activities.

Research Reports By CurrentPartnering

Found 335 publications
Global Precision Medicine Partnering 2010-2018: Deal trends, players and financials US$ 3,495.00 Nov, 2018 1000 pages
Global Biotech Partnering Terms and Agreements 2012-2018: Deal trends, players and financials US$ 2,995.00 Nov, 2018 1000 pages
Global Antibody Partnering Terms and Agreements 2010-2018: Deal trends, players and financials US$ 2,995.00 Nov, 2018 850 pages
Global Biomarker Partnering Terms and Agreements 2010-2018: Deal trends, players and financials US$ 2,995.00 Nov, 2018 658 pages
Global Diagnostics Partnering 2010-2018: Deal trends, players and financials US$ 3,495.00 Nov, 2018 1000 pages
Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2012-2018 US$ 2,995.00 Nov, 2018 1000 pages
Global Companion Diagnostics Partnering 2010-2018: Deal trends, players and financials US$ 2,995.00 Nov, 2018 248 pages
Global In Vitro Diagnostics Partnering 2010-2018: Deal trends, players and financials US$ 2,995.00 Nov, 2018 660 pages
Global Antibiotics Partnering Terms and Agreements 2010 to 2018: Deal trends, players and financials US$ 2,995.00 Nov, 2018 222 pages
Global Artificial Intellgence (AI) LPartnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010 to 2018 US$ 1,995.00 Nov, 2018 140 pages
Global Drug Delivery Partnering 2010-2018: Deal trends, players and financials US$ 3,495.00 Nov, 2018 1000 pages
Global Cancer Diagnostics Partnering 2010-2018: Deal trends, players and financials US$ 2,995.00 Nov, 2018 700 pages
Global Cancer Vaccine Partnering 2010-2018: Deal trends, players and financials US$ 2,995.00 Nov, 2018 200 pages
Global Pharmaceutical Partnering Terms and Agreements 2012-2018: Deal trends, players and financials US$ 2,995.00 Nov, 2018 1000 pages
Global Licensing Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2012-2018 US$ 2,995.00 Nov, 2018 2500 pages
Global Option and Evaluation Partnership Terms and Agreements in Pharma, Biotech and Diagnostics 2012-2018 US$ 2,995.00 Nov, 2018 800 pages
Global Vaccine Partnering Terms and Agreements 2010-2018: Deal trends, players and financials US$ 2,995.00 Nov, 2018 700 pages
Global Asset Purchase Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2012 to 2018 US$ 2,995.00 Nov, 2018 750 pages
Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2010-2018: Deal trends, players and financials US$ 2,995.00 Nov, 2018 300 pages
Global Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2012 to 2018 US$ 2,995.00 Nov, 2018 1200 pages
Global Stem Cell Partnering 2010-2018: Deal trends, players and financials US$ 2,995.00 Nov, 2018 370 pages
Global Infectious Vaccines Partnering Terms and Agreements 2010 to 2018: Deal trends, players and financials US$ 2,995.00 Nov, 2018 450 pages
Global Inflammation Partnering 2012 to 2018 US$ 1,995.00 Oct, 2018 200 pages
Global Head and Neck Cancer Partnering 2012 to 2018 US$ 1,995.00 Oct, 2018 150 pages
Global Bladder Cancer Partnering 2012 to 2018 US$ 1,995.00 Oct, 2018 150 pages
Global Genitourinary Partnering 2012-2018: Deal trends, players and financials US$ 2,995.00 Oct, 2018 500 pages
Global Systemic Lupus Erythematosus Partnering 2012 to 2018 US$ 1,995.00 Oct, 2018 100 pages
Global Myocardial Infarction Partnering 2012 to 2018 US$ 1,995.00 Oct, 2018 100 pages
Global Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2012- 2018 US$ 2,995.00 Oct, 2018 1000 pages
Global Pediatrics Partnering 2012-2018: Deal trends, players and financials US$ 2,995.00 Oct, 2018 500 pages
Global Contraception Partnering 2012-2018 US$ 1,995.00 Oct, 2018 150 pages
Global Pain Partnering 2012 to 2018 US$ 1,995.00 Oct, 2018 200 pages
Global Musculoskeletal Symptoms Partnering 2012-2018 US$ 1,995.00 Oct, 2018 100 pages
Global Hypertension Partnering 2012 to 2018 US$ 1,995.00 Oct, 2018 100 pages
Global COPD Partnering 2012 to 2018 US$ 1,995.00 Oct, 2018 100 pages
Global Monoclonal Antibody Partnering Terms and Agreements 2012-2018: Deal trends, players and financials US$ 2,995.00 Oct, 2018 500 pages
Global Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech 2012-2018 US$ 2,995.00 Oct, 2018 1000 pages
Global Dementia Partnering 2012 to 2018 US$ 1,995.00 Oct, 2018 100 pages
Global Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2010-2018 US$ 2,995.00 Oct, 2018 344 pages
Global Public Health Partnering 2012-2018: Deal trends, players and financials US$ 2,995.00 Oct, 2018 1000 pages
Global Prenatal Screening Partnering 2012 to 2018 US$ 1,995.00 Oct, 2018 100 pages
Global Learning Disability Partnering 2012 to 2018 US$ 1,995.00 Oct, 2018 100 pages
Global Molecular Diagnostics 2012-2018: Deal trends, players, financials and forecasts US$ 2,995.00 Oct, 2018 495 pages
Global Viral Partnering 2012-2018: Deal trends, players and financials US$ 2,995.00 Oct, 2018 500 pages
Global Sleep Disorders Partnering 2012 to 2018 US$ 1,995.00 Oct, 2018 100 pages
Global Motor Neurone Disease Partnering 2012 to 2018 US$ 1,995.00 Oct, 2018 150 pages
Global Clinical Stage Partnering Terms and Agreements in Pharma and Biotech 2012-2018 US$ 2,995.00 Oct, 2018 1000 pages
Global Epilepsy Partnering 2012 to 2018 US$ 1,995.00 Oct, 2018 150 pages
Global Anthrax Partnering 2012 to 2018 US$ 1,995.00 Oct, 2018 150 pages
Global Respiratory Partnering 2012-2018: Deal trends, players and financials US$ 2,995.00 Oct, 2018 800 pages
1 2 3 4 5 ... 7
Skip to top

Analytics & News by CurrentPartnering